Compare Match Group Inc (MTCH) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs TransMedics Group Inc — how do they compare? Match Group Inc trades at $41.09 (market cap $9.53B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Match Group Inc is far larger — about 3.5× TransMedics Group Inc's market cap, and Match Group Inc pays a 1.93% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Match Group Inc for 115 Days and TransMedics Group Inc for 24 Days on average.
| MTCH | TMDX | |
|---|---|---|
Market Cap | $9.53B | $2.74B |
Volume | 3,228,794 | 949,331 |
Sector | Media | Health |
52-Week High | $44.40 | $150.42 |
52-Week Low | $28.90 | $61.99 |
Typical Hold Time | 115 Days | 24 Days |
Enterprise Value | $12.49B | $3.13B |
Dividend Yield | 1.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $41.50, up 1.57% with a bullish technical signal. The stock shows strong fundamentals with 74.8% gross margins and consistent earnings beats in three of the last four quarters. Analyst consensus is bullish with a $42.29 price target, while recent news highlights Tinder's AI initiatives and Hinge's growth driving investor optimism.
The outlook remains positive with projected 20.16% net margins for 2026, though high debt levels and competitive pressures present risks. Current valuation at 14.71 P/E offers reasonable entry point for growth exposure, supported by strong cash flow generation and institutional accumulation.
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
